ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,283,159 | -11.4% | 47,279 | +0.4% | 0.03% | -10.3% |
Q2 2023 | $1,448,211 | -16.6% | 47,112 | -2.3% | 0.03% | -27.5% |
Q1 2023 | $1,736,917 | -3.6% | 48,207 | +5.8% | 0.04% | -20.0% |
Q4 2022 | $1,801,150 | -2.1% | 45,576 | -0.4% | 0.05% | 0.0% |
Q3 2022 | $1,839,000 | -4.0% | 45,766 | +0.4% | 0.05% | -13.8% |
Q2 2022 | $1,916,000 | +7.8% | 45,575 | -0.1% | 0.06% | +38.1% |
Q1 2022 | $1,778,000 | -2.2% | 45,641 | +0.1% | 0.04% | 0.0% |
Q4 2021 | $1,818,000 | +7.0% | 45,612 | -3.0% | 0.04% | -6.7% |
Q3 2021 | $1,699,000 | -9.0% | 47,027 | +3.2% | 0.04% | -18.2% |
Q2 2021 | $1,868,000 | -6.0% | 45,561 | -0.0% | 0.06% | -32.9% |
Q1 2021 | $1,988,000 | -12.8% | 45,579 | +0.1% | 0.08% | -18.8% |
Q4 2020 | $2,280,000 | – | 45,550 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 2,680,644 | $106,824,000 | 67.12% |
SIGULER GUFF ADVISERS, LLC | 6,761,970 | $269,465,000 | 56.37% |
Vantage Consulting Group Inc | 4,601,152 | $183,355,000 | 49.30% |
Indie Asset Partners, LLC | 805,982 | $32,118,000 | 23.31% |
HARVARD MANAGEMENT CO INC | 3,464,990 | $138,080,000 | 12.96% |
Brown University | 621,759 | $24,777,000 | 6.04% |
Overbrook Management Corp | 729,125 | $29,056,000 | 5.86% |
Bleichroeder LP | 824,033 | $32,838,000 | 5.13% |
Geo Capital Gestora de Recursos Ltd | 200,692 | $7,998,000 | 3.81% |
Lagoda Investment Management, L.P. | 140,435 | $5,596,000 | 2.65% |